Adiponectin inversely correlates with high sensitive c-reactive protein and triglycerides, but not with insulin sensitivity, in apparently healthy Japanese men

被引:25
作者
Komatsu, Mitsuhisa
Ohfusa, Hirokazu
Aizawa, Toru
Hashizume, Kiyoshi
机构
[1] Shinshu Univ, Grad Sch Med, Dept Aging Med & Geriat, Matsumoto, Nagano 3908621, Japan
[2] Shinshu Univ, Ctr Med Educ, Matsumoto, Nagano 3908621, Japan
[3] Nagano Red Cross Hosp, Nagano 3808582, Japan
关键词
adiponectin; metabolic syndrome; insulin resistance; triglyceride; high sensitive CRP;
D O I
10.1507/endocrj.K07-032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adiponectin, an antiatherogenic peptide, has diverse biological actions on insulin sensitivity, inflammation and lipid metabolism. To explore physiological and pathophysiological significance of adiponectin in the Japanese general population, we systematically analyzed the relationship between adiponectin and high sensitive CRP (hsCRP), lipids, insulin sensitivity, and anthropometric parameters in 166 consecutive adult male health examinees. By univariate analysis, serum adiponectin was positively correlated with age and HDL-cholesterol, and inversely correlated with fasting plasma glucose, fasting insulin, homeostasis model assessment insulin-resistance, waist, body mass index, triglycerides and hsCRP. However, multivariate analysis revealed that adiponectin independently correlated with triglycerides (r = -0.243, P = 0.0033) and hsCRP (r = -0.262, P = 0.0015) but not with all other variables. Adiponectin was lower and hsCRP higher in the subjects with metabolic syndrome (n = 22) than in those without it (n = 144) (adiponectin, 5.4 +/- 2.8 vs 7.5 +/- 4.2 [mu g/ml, p = 0.002; hsCRP, 832 +/- 665 vs 470 +/- 524 ng/ml, p = 0.0004). Current findings suggest that relative importance of hypertriglyceridemia and enhanced inflammation, rather than insulin resistance, as the downstream events of hypoadiponectinemia leading to atherosclerosis in the Japanese general population.
引用
收藏
页码:553 / 558
页数:6
相关论文
共 33 条
[1]   Decreased plasma adiponectin concentration in patients with essential hypertension [J].
Adamczak, M ;
Wiecek, A ;
Funahashi, T ;
Chudek, J ;
Kokot, F ;
Matsuzawa, Y .
AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (01) :72-75
[2]  
ALTINOVA AE, 2007, ENDOCRINE J
[3]  
[Anonymous], 2005, Nihon Naika Gakkai Zasshi, V94, P794
[4]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[5]   Association between adiponectin and mediators of inflammation in obese women [J].
Engeli, S ;
Feldpausch, M ;
Gorzelniak, K ;
Hartwig, F ;
Heintze, U ;
Janke, J ;
Möhlig, M ;
Pfeiffer, AFH ;
Luft, FC ;
Sharma, AM .
DIABETES, 2003, 52 (04) :942-947
[6]   The relationship between insulin sensitivity and serum adiponectin levels in three population groups [J].
Ferris, WF ;
Naran, NH ;
Crowther, NJ ;
Rheeder, P ;
van der Merwe, L ;
Chetty, N .
HORMONE AND METABOLIC RESEARCH, 2005, 37 (11) :695-701
[7]   Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy [J].
Fujita, Hlroki ;
Morii, Tsukasa ;
Koshimura, Jun ;
Ishikawa, Motoko ;
Kato, Masako ;
Miura, Takeshi ;
Sasaki, Hiroshi ;
Narita, Takuma ;
Ito, Seiki ;
Kakei, Masafumi .
ENDOCRINE JOURNAL, 2006, 53 (06) :745-752
[8]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[9]   Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats [J].
Gill, R ;
Kemp, JA ;
Sabin, C ;
Pepys, MB .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2004, 24 (11) :1214-1218
[10]   C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction [J].
Griselli, M ;
Herbert, J ;
Hutchinson, WL ;
Taylor, KM ;
Sohail, M ;
Krausz, T ;
Pepys, MB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (12) :1733-1739